2025 annual financial data
TG Therapeutics 2025 Operating margin
Direct answer
Operating margin was 20.01%.
Operating income was 123,324,000 USD and net income was 447,179,000 USD.
Operating cash flow was -24,772,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 616,287,000 USD
- Operating income
- 123,324,000 USD
- Net income
- 447,179,000 USD
- Operating cash flow
- -24,772,000 USD